By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – XDx today said that it has established a $12.5 million senior secured loan facility with GE Capital, Healthcare Financial Services.

The Brisbane, Calif.-based molecular diagnostics firm said that it would use the funds as working capital to support expanded commercialization of its AlloMap multi-gene molecular expression tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.